Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Can Biomarkers Predict Causes of Death in AF?

Circulation; ePub 2018 Jun 5; Sharma, et al

In patients with atrial fibrillation (AF), biomarkers are a strong predictor of cause-specific death and may improve the ability to discriminate among patients’ risks for different causes of death, a recent study suggests. The ARISTOTLE randomized 18,201 patients with AF to apixaban or warfarin. Biomarkers were measured at randomization in 14,798 patients with 1.9 years median follow-up. Researchers found:

  • 1,272 patients died: 652 (51%) cardiovascular (CV); 32 (3%) bleeding; and 588 (46%) non-CV/non-bleeding deaths.
  • Among CV-deaths, 255 (39%) were sudden cardiac deaths, 168 (26%) heart failure (HF), and 106 stroke/systemic embolism (SE) (16%) deaths.
  • Biomarkers were the strongest predictors of cause-specific death: a doubling of troponin-T was most strongly associated with sudden death (HR, 1.48), NT-proBNP with HF death (HR, 1.62), and GDF-15 with bleeding death (HR, 1.72).
  • Prior stroke/SE followed by troponin-T were the most predictive for stroke/SE death.

Citation:

Sharma A, Hijazi Z, Andersson U, et al. The use of biomarkers to predict specific causes of death in patients with atrial fibrillation: Insights from the ARISTOTLE trial. [Published online ahead of print June 5, 2018]. doi:10.1161/CIRCULATIONAHA.118.034125.

This Week's Must Reads

Evolocumab Lowers LDL-C in Patient Subgroups, Clin Cardiol; 2018 Oct 21; Stroes, Robinson, et al

Is Further Lowering of LDL-C in Patients Safe?, JAMA Cardiol; 2018 Sep; Sabatine, Wiviott, et al

Effects of Primary Prevention on CVD Event Risk, J Manag Care Spec Pharm; 2018 Nov; Han, et al

FH Patients with Diabetes at Elevated Risk for CVD, J Clin Lipidol; ePub 2018 Sep 17; Paquette, et al

Long-Term Benefit to Statin Eligibility, JAMA Cardiol; ePub 2018 Oct 24; Thanassoulis, et al

Must Reads in Arrhythmias & EP

Cancer Treatment-Induced Arrhythmia with TCAs, J Am Heart Assoc; ePub 2018 Oct 13; Nickel, et al

Effect of AF on Outcomes in Women Undergoing TAVI, Am J Cardiol; ePub 2018 Sep 7; Guedeney, et al

Psychosocial Stressors & AF in Older Women, Am J Cardiol; ePub 2018 Aug 17; Westcott, et al

Dementia Progression in Men and Women with AF, Am J Cardiol; ePub 2018 Aug 3; Golive, et al

SSRIs & Bleeding Risk in AF Patients Taking Anticoagulants, J Am Heart Assoc; ePub 2018 Jul 27; Quinn, et al